To evaluate the possibility of using nearinfrared spectroscopy (NIRS) to measure tissue oxygenation (StO 2 ) during hyperbaric oxygen (HBO) therapy. Nine healthy volunteers (1 female) age 25-37 years, breathed air or oxygen. Tissue oxygenation was measured using NIRS on the thumb. Subjects were blinded to breathing gas. A range of partial pressures of oxygen were administered in 10-min intervals: 21, 101, 21 kPa (compression to 280 kPa), 59, 280, 59 (decompression), 21 kPa. Data were averaged over last 5 min at each pressure. When switching from air to normobaric oxygen (NBO 101 kPa) StO 2 increased from 83% (82-85%, median and interquartile range) to 85% (84-87%) (P \ 0.01), while when switching from air at pressure (59 kPa O 2 ) to HBO (280 kPa), StO 2 increased from 85% (85-86%) to 88% (87-89%) (P \ 0.001). There was no difference between baseline StO 2 while air breathing before NBO or after decompression. Values did not reach the maximal value of 100% at any point. The changes in hemoglobin oxygen saturation in tissue registered by the NIRS monitor when switching from air to oxygen followed inspired PO 2 under normobaric and hyperbaric conditions.
Introduction
Hyperbaric oxygen therapy (HBO) is used in the treatment of several clinical conditions where tissue hypoxia is intrinsic to the problem, for example in severe soft tissue infections, acute traumatic ischemia, carbon monoxide poisoning, delayed radiation injury, intracranial abscesses (Kurschel 2006) osteomyelitis, selected problem wounds and decompression illness (Gesell 2008) . The method is defined as oxygen breathing at a higher than ambient pressure (approximately 1.0 bar at sealevel), commonly an increase of 0.5-1.8 bars for therapeutical use. The clinical indications for HBO therapy have not yet been fully evaluated. Among other things, the lack of reliable and suitable monitoring methods of the oxygen content in the target tissues makes evaluation and dosage of the method difficult.
Inadequate tissue oxygenation may exist while vital signs, such as blood pressure, heart rate and arterial oxygen saturation as measured with pulse oximetry (SpO 2 ) appear normal. Near-infrared spectroscopy (NIRS), like pulse oximetry, measures the changes in blood oxygen saturation non-invasively (Greisen 2006) . However, an important difference is that while pulse oximetry measures the systemic oxygen saturation of arterial blood, tissue oxygen saturation (StO 2 ), as measured with NIRS, monitors changes in the regional oxygen saturation of predominantly venous blood. This would presumably make NIRS an interesting method to evaluate oxygen content in the tissues during both normobaric and hyperbaric oxygen administration, whereas SpO 2 quickly reaches the maximum value of 100% when the oxygen content in the breathing gas is elevated.
NIRS has not yet been evaluated for use under hyperbaric conditions. We tested NIRS monitoring to see if this technique would make it possible to follow individual (StO 2 ) changes in regional tissue on healthy subjects during NBO and HBO administration.
Methods
Nine healthy non-smoking subjects were recruited to participate in the study. The volunteers were all recreational divers; eight males and one female, age median 30 years (range 28-31) and with a median body mass index of 27 kg/m 2 (range 26-28). All subjects gave their written informed consent to participation prior to the tests. The study was conducted in conformity with Ethical Principles for Medical Research Involving Human Subjects (World Medical Association Declaration of Helsinki, Geneva 2000) and was approved by the Local Ethics Committee.
Tests were performed in a hyperbaric multi-place chamber (Kockums, Sweden) using hoods (CASTAR, STARMed) supplied with either air or oxygen during the experiment. Tissue oxygenation, as measured with NIRS, and the tissue hemoglobin index (THI) were both monitored with an Inspectra TM StO 2 monitor (Hutchinson Technology, MN, USA) inside the chamber using a probe placed on the thenar eminence (thumb). Heart rate and blood pressure were monitored with a Propaque monitor 106 EL (Protocol Systems Inc, Beaverton Oregon, USA), also inside the chamber. The environmental temperature inside the chamber was monitored using an esophageal probe hanging in free air inside chamber connected to the Propaque monitor.
Both monitors were tested for use under hyperbaric conditions (maximum 3.5 bars) according to a risk analysis protocol in cooperation with the local medical technical department.
Experimental procedures
Subjects were positioned in a semi-recumbent position on a stretcher inside the hyperbaric chamber. The test protocol was started after 10 min of rest. Different O 2 partial pressures were administered in the following 10-min intervals: normobaric: 21 kPa (air), 101 kPa (100% O 2 ) and 21 kPa; hyperbaric: (compression to 2.8 bars), 59 kPa (air), 280 kPa (100% O 2 ), 59 kPa (decompression to 1.0 bar including a safety stop at 1.3 bars for 5 min).
The chamber was ventilated to hold an environmental temperature of 20-25°C. The subjects were blinded as to when they were breathing either air or oxygen.
At every minute, tissue oxygenation, THI and heart rate were measured, while blood pressure was measured every 5 min. THI values lower than 5 indicate that the accuracy of the StO 2 value may be reduced, values well above 5 was measured for all the subjects in all the procedures during the tests (Table 1) .
The environmental temperature inside chamber was also monitored every minute.
MAP (mean arterial blood pressure) was calculated manually according to the formula
Bloodpressure during later analysis of the data. In one subject (subject A), it was not possible to calculate blood pressure due to failure of equipment during the test. As MAP was consistent for all other subjects measured (B-I), we chose not to exclude subject A. All data reported here were averaged over the last 5 min at each pressure.
Statistical evaluation
Nonparametric statistical procedures were performed throughout the study unless otherwise stated. Median values of NIRS (%) during the last 5 min of the different pressure increased from 85% (85-86%) to 88% (87-89%), P \ 0.001 (Figs. 1, 2, 3) . A change in StO 2 when increasing the oxygen partial pressure of the breathing gases was seen within the first 2 min of the 10-min period. On return to normobaric air breathing (21 kPa O 2 ), StO 2 reached its baseline value within 2 min for all. Values did not reach the maximum 100% value at any point. A THI of 14-18 (Table 1) indicated that an adequate StO 2 signal was present for all subjects in all of the tests. Heart rate decreased when switching from air to NBO, changing from 62 (59-66) to 58 (57-61) beats/min, P \ 0.001 and also decreased when switching from air at pressure to HBO, moving from 60 (57-67) to 54 (52-56), P \ 0.001 (Table 1) . MAP did not change significantly when switching from air to NBO and when switching pressurized air to HBO (Table 1) .
There was no significant difference between baseline StO 2 , heart rate or MAP during air breathing before NBO and air breathing after decompression (Table 1) .
Discussion
The rationale for using HBO is to counteract hypoxia in deep soft tissues. The degree of oxygenation of these tissues cannot easily be measured, because it is not always reflected in systemic oxygen content measurements, such as blood gas analysis. To verify that HBO therapy does allow oxygen to reach the target tissues and also to evaluate at what dose it reverses tissue hypoxia, an efficacious measure of oxygen content in tissues is needed. As oxygen levels in tissues can change very quickly, in the order of minutes, monitoring should preferably be carried out during HBO administration. There are two basic kinds of oxygenation measurement, a measure of hemoglobin oxygen saturation in blood and a measure of the partial pressure of oxygen in a vessel or tissue. Arterial blood-gas monitoring measures the systemic oxygen level and not the oxygen level in target tissues, and is therefore of limited value in evaluating NBO or HBO therapies.
Pulse oximetry, which measures the oxygen saturation of hemoglobin in arterial blood using near-infrared light, benefits from being non-invasive. However, measurements reflects the central oxygenation in arterial blood and the maximum value (100% SpO 2 ) is quickly reached when breathing air or even slightly elevated levels of oxygen (just above 21 kPa) and therefore the technique is of no use for the evaluation of oxygen levels in the tissue during NBO (101 kPa) or HBO (in this study-280 kPa) therapies.
Transcutaneous oximetry (TCPO 2 ), uses a Clark's polarographic electrode that can sense oxygen, placed on the skin (Mathieu 2007 ). The method is also non-invasive and measures the partial pressure of oxygen in the skin only. This technique has been used to evaluate the use of HBO in selected problem wounds (Mathieu 2007 ), but as the technique can measure skin or superficial tissue oxygenation only, it is of little or no value in monitoring oxygenation in severe soft tissue infectious diseases or crush injuries where the clinical problem is situated in the deeper anatomical layers. The slow response of transcutaneous measurement is another drawback.
NIRS is another non-invasive technique, which can be used to assess the level of oxidized and reduced forms of oxygen carriers. NIRS can be used to monitor StO 2 at depths up to a maximum 4 cm of tissue-whether skin, subcutaneous tissue or muscle (Boushel 2001) . The volume of tissue studied varies according to the device, but is approximately a 15-mm cube and StO 2 will vary with changes in the local supply and consumption of oxygen within the sample (Ledermann 2006; Kragelj 2000) . The THI measurement is an indicator of signal strength based on the measure of the total amount of hemoglobin present in the monitored tissue. NIRS has been used clinically in different settings, for example to measure prognostic value in septic patients (Creteur 2007) , to assess cerebral oxygenation index in children (Nagdyman 2005) (Nagdyman 2008) and to assess dynamic tissue O 2 saturation response (Gomez 2008 ). The present study was designed to evaluate if NIRS could be used to monitor oxygen saturation in peripheral tissues under hyperbaric conditions. The Inspectra NIRS monitor was in this study used inside the chamber at 2.8 bars. The Inspectra NIRS monitor has been evaluated for use on the thenar eminence only; however, there are other NIRS monitors available with probes evaluated for use in other parts of the body. Our choice of monitor was made because it could be used safely inside the hyperbaric chamber. In a previous study, Litscher et al. (1997) evaluated NIRS using a different type of monitor (INVOS 3100 cerebral oximeter) in measuring cerebral oxygenation during HBO. They used a passthrough penetrator in the chamber wall, situating the monitor outside the chamber with the probe attached to the subjects inside chamber. Their protocol involved a maximum pressure of 2.5 bars (250 kPa), testing 7 healthy subjects with the NIRS probe attached to the forehead. It was found that NIRS cerebral oxygenation measurements mirrored changes in inhaled oxygen during the HBO period.
Although the results of the Litscher study are similar to those of the present study, one difference is that on returning to ground level (21 kPa oxygen) following the period of HBO, at 15 min the NIRS values had still not returned to the baseline levels recorded prior to the increase in pressure. A possible explanation for this finding is that the StO 2 measurements were made in two very different tissues-cerebrally in the Litscher study and in the present study, in peripheral muscle (thenar muscle); the difference in delay of return to baseline StO 2 levels after HBO exposure presents an interesting issue for further tests.
The main finding of the present study was that tissue oxygen saturation (as measured by NIRS) increased significantly, but did not reach 100% during hyperbaric oxygen. In addition, the results suggest that this method could be used to follow changes in tissue saturation during treatment with HBO.
Prior to the use of NIRS monitors for clinical practice under hyperbaric conditions, further test are necessary to ensure that the technical specifications of NIRS monitors and specifically the Inspectra model, are correct for safe and accurate use inside hyperbaric chambers and may be recommended for this purpose.
Conclusion
Tissue oxygenation increased during NBO and HBO exposures in healthy resting subjects as measured with the Inspectra NIRS monitor to evaluate StO 2 . Changes in StO 2 followed inspired PO 2 changes. We found that NIRS measured in this way should be a promising technology for monitoring oxygen levels in target tissues during NBO and HBO therapies.
